The International Conference on Bioinformatics, Biomedicine, Biotechnology, and Computational Biology (EUIC3BCB) is slated to occur in Detroit, USA, on May 8th, 2024. This conference series convenes periodically to facilitate interactive discussions and presentations on cutting-edge topics in bioinformatics, biomedicine, biotechnology, and computational biology. Welcoming participants globally, the event encourages the establishment of professional networks and exploration of career opportunities within the region. Attendees will have the opportunity to exchange knowledge, explore current technologies, techniques, and solutions in biotechnology, and engage with diverse stakeholders from research, academia, industry, and government sectors. EUIC3BCB aims to foster collaborations and provide insights into advancements in these fields across different countries.

Read on eurasiaweb.com

The SAE 2024 Injectable Drug Delivery conference, scheduled from Wed, 08 May 2024 at 08:30 to Thu, 09 May 2024 at 17:00, centers on the interplay between device development and drug product interaction. Featuring prominent speakers from big pharma, the event offers insights into formulation strategies, extractables, leachables, and toxicological testing. Case studies from industry leaders like Sanofi, Roche, and Bayer explore advanced drug products and user-driven platform development, providing a unique opportunity for focused discussions and networking. This specialized conference offers tailored insights for device developers, setting it apart from broader industry gatherings. 

[Read on smgconferences](https://www.smgconferences.com/pharmaceuticals/uk/injectable-drug-delivery/booknow)

Join the Digital Health Partnering Summit, uniting Pharma Biotech's top Dealmakers, Innovators, Investors, and Decision-makers. This exclusive event explores cutting-edge Digital Health Therapies & Technologies, fostering collaboration, business prospects, and innovation. Gain insights via engaging keynotes, panels, interactive sessions, and networking. Stay ahead in the evolving Digital Health landscape, addressing future challenges and opportunities.

Read on pharma-partnering-summit.com

The 57th Annual Meeting of the Association for European Paediatric and Congenital Cardiology is set to convene in Porto, Portugal, from May 8th to 11th, 2024. Hosted by the Local Organising Committee in collaboration with the AEPC Scientific Committee, this event promises a dynamic platform for health professionals and researchers. Expect a stimulating scientific program featuring esteemed speakers addressing pertinent topics and emerging challenges in paediatric and congenital cardiology. The venue, Centro de Congressos da Alfândega do Porto, situated amidst the historic charm of Porto's old city center by the Douro River, adds to the allure of this insightful gathering. 

[Read on aepc2024.org](https://www.aepc2024.org/registration-hotels-and-travel/register-now/)

Join NRHA and rural health leaders nationwide in the bayou for the 9th Rural Hospital Innovation Summit, 47th Annual Rural Health Conference, and related events, happening May 7-10 in New Orleans. With 80+ practical sessions, this is the ultimate gathering for rural health professionals seeking inspiration and strategies to enhance rural healthcare. Open to all interested in rural health.

Read on ruralhealth.us

Healthcare is evolving with technology, offering care providers both challenges and opportunities in digital transformation. Join over 6,000 health professionals, a dynamic event designed for networking and learning. DHF unites professionals from hospitals, primary care, allied care, aged care, pharmacy, research, and policy to explore the changing landscape of healthcare.

Read on digitalhealthfest.com.au

The 4th Annual Ligase Targeting Drug Development Summit, scheduled from May 7 to May 9, 2024, addresses challenges in developing mono- and bivalent degraders and harnessing the potential of E3 ligases. With a focus on discovering, validating, and utilizing novel E3 ligases, the summit aims to overcome obstacles in ligase screening, structural characterization, and assessing therapeutic efficacy. Bringing together over 80 ligase experts, the event features data-driven presentations, technical discussions, and interactive sessions. The Ligase Targeting Drug Development Summit serves as a collaborative platform to unlock therapeutic opportunities, advancing the field of drug development through insights and expertise. 

[Read on ligase-drugdevelopment.com](https://ligase-drugdevelopment.com/take-part/register/)

The 3rd Next Generation RNA Therapeutics Summit, scheduled from May 7th to May 9th, 2024, is set to accelerate the translation of advanced RNA therapies into safe and effective clinical candidates across various diseases. This summit delves into pioneering RNA modalities like circular RNA and self-amplifying RNA (saRNA), addressing challenges in quality, stability, and large-scale manufacturing. With substantial investments like Orbital Therapeutics’ $270 million Series A financing reflecting industry interest, the event gathers 120+ expert leaders in Discovery, R&D, Engineering, Preclinical Translation, and CMC. Their collective focus aims to propel these next-gen RNA therapies from discovery to the clinic, expediting their availability to patients while unlocking vast therapeutic and commercial potentials in this evolving field. 

[Read on www.next-gen-rna.com](https://www.next-gen-rna.com/take-part/register/)

The 3rd International Infection Prevention and Control Conference (IPC-2023-KSA) focuses on contemporary oncology advancements, treatments, and guidelines, scheduled from May 4th to 5th, 2024. Featuring keynote lectures covering diverse facets including Cancer Science, Drug Development, Precision Medicine, Immunotherapy, and more, this program facilitates dynamic networking among professionals. Encouraging collaboration and knowledge exchange, it aims to inspire innovative ideas for enhanced patient care in the ever-evolving field of oncology.

 [Read on maarefah.eventsair](https://maarefah.eventsair.com/iosc-3/)

You're cordially invited to the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII), following the resounding success of its sixteen predecessors. This conference, scheduled for May 5-8, 2024, in Madrid, Spain, upholds its tradition of insightful debates and the well-received format of previous editions. EILAT XVII remains committed to delivering comprehensive progress updates on new antiepileptic drugs in different developmental stages, while also unveiling novel discoveries in second-generation treatments. Join us for a vital exchange of knowledge and advancements in the field of epilepsy management.

Read on eilatxvii.com